Does INOTERSEN Cause Neoplasm malignant? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neoplasm malignant have been filed in association with INOTERSEN. This represents 0.3% of all adverse event reports for INOTERSEN.
5
Reports of Neoplasm malignant with INOTERSEN
0.3%
of all INOTERSEN reports
3
Deaths
1
Hospitalizations
How Dangerous Is Neoplasm malignant From INOTERSEN?
Of the 5 reports, 3 (60.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INOTERSEN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does INOTERSEN Cause?
Platelet count decreased (334)
Protein urine present (269)
Glomerular filtration rate decreased (264)
Urine protein/creatinine ratio increased (249)
Blood creatinine increased (214)
Fatigue (198)
Bacterial test positive (193)
Urine abnormality (184)
Nausea (152)
Malaise (145)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which INOTERSEN Alternatives Have Lower Neoplasm malignant Risk?
INOTERSEN vs INOTUZUMAB OZOGAMICIN
INOTERSEN vs INSULIN
INOTERSEN vs INSULIN ASPART
INOTERSEN vs INSULIN ASPART\INSULIN DEGLUDEC
INOTERSEN vs INSULIN BEEF